These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36029298)

  • 21. IBD: which patients with IBD are at risk of venous thromboembolism?
    Koutroubakis IE
    Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):307-8. PubMed ID: 20523349
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of venous thromboembolism in hospitalized patients with inflammatory bowel disease.
    Chande N
    Inflamm Bowel Dis; 2013 Mar; 19(3):669-71. PubMed ID: 23385239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease.
    Allen JI
    Dig Dis Sci; 2013 Jan; 58(1):1-4. PubMed ID: 23179161
    [No Abstract]   [Full Text] [Related]  

  • 24. Venous thromboembolism following colorectal resection.
    El-Dhuwaib Y; Selvasekar C; Corless DJ; Deakin M; Slavin JP
    Colorectal Dis; 2017 Apr; 19(4):385-394. PubMed ID: 27654996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis.
    Alhassan N; Trepanier M; Sabapathy C; Chaudhury P; Liberman AS; Charlebois P; Stein BL; Lee L
    Tech Coloproctol; 2018 Dec; 22(12):955-964. PubMed ID: 30569263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous and arterial thromboembolism in patients with inflammatory bowel diseases.
    Stadnicki A; Stadnicka I
    World J Gastroenterol; 2021 Oct; 27(40):6757-6774. PubMed ID: 34790006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Comparable to That in Western Patients?
    Hwang SW
    Gut Liver; 2022 Jul; 16(4):495-496. PubMed ID: 35843682
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA.
    Bodger K
    Aliment Pharmacol Ther; 2022 Oct; 56(7):1211-1212. PubMed ID: 36071012
    [No Abstract]   [Full Text] [Related]  

  • 29. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.
    Grainge MJ; West J; Card TR
    Lancet; 2010 Feb; 375(9715):657-63. PubMed ID: 20149425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additional published study for the scoping review on venous thromboembolism in pediatric inflammatory bowel disease.
    Ding Z; Zachos M
    J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1202. PubMed ID: 38385673
    [No Abstract]   [Full Text] [Related]  

  • 31. Venous thromboembolism with inflammatory bowel disease.
    Freeman HJ
    World J Gastroenterol; 2008 Feb; 14(7):991-3. PubMed ID: 18286676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity.
    Chu TPC; Grainge MJ; Card TR
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1099-1108. PubMed ID: 30294897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous Thromboembolism in Children with Inflammatory Bowel Disease: When is the Right Time for Thromboprophylaxis?
    Torrente F; Hansen R
    J Crohns Colitis; 2022 Jun; 16(5):691-692. PubMed ID: 34979551
    [No Abstract]   [Full Text] [Related]  

  • 34. Patient awareness of extraintestinal manifestations of inflammatory bowel disease.
    Huang V; Mishra R; Thanabalan R; Nguyen GC
    J Crohns Colitis; 2013 Sep; 7(8):e318-24. PubMed ID: 23265763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Ghosh T; Ford AC; Everett S
    Lancet; 2010 May; 375(9727):1690; author reply 1690-1. PubMed ID: 20472161
    [No Abstract]   [Full Text] [Related]  

  • 36. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Valsecchi ME; Damilano CP
    Lancet; 2010 May; 375(9727):1690; author reply 1690-1. PubMed ID: 20472163
    [No Abstract]   [Full Text] [Related]  

  • 37. The Risk of Blood Transfusion With the Use of Pharmacologic Venous Thromboembolism Prophylaxis During Hospitalization for Inflammatory Bowel Disease Exacerbation: A Time to Event Analysis.
    Khuwaja S; Kohn N; Sanghani SS; Khan S; Swaminath A; Sultan K
    Am J Ther; 2023 May; 30(3):e288-e291. PubMed ID: 37278710
    [No Abstract]   [Full Text] [Related]  

  • 38. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Koutroubakis IE; Pena AS
    Lancet; 2010 May; 375(9727):1689; author reply 1690-1. PubMed ID: 20472159
    [No Abstract]   [Full Text] [Related]  

  • 39. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Thachil J
    Lancet; 2010 May; 375(9727):1689; author reply 1690-1. PubMed ID: 20472160
    [No Abstract]   [Full Text] [Related]  

  • 40. Venous thromboembolism risk in patients with inflammatory bowel disease: defining the benefits of pharmacologic prophylaxis.
    Sultan K; Brun A; Spyropoulos AC
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1577. PubMed ID: 24703865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.